h/t Hot Air
In a paper published Friday in the Journal of Clinical Investigation, Casadevall and a colleague, Dr. Liise-anne Pirofski, argued that collecting blood serum or plasma from previously infected people might be the best hope for treating severe cases of COVID-19, the disease caused by the virus, at least until a better treatment can be developed.
We call it "passive vaccination" (see wiki article) and nowadays there is methods from producing the necessary antibodies from animals* - first producing the immunizing protein in bacterial factories - "Protein production" (wiki)) and not bleeding people - it's 21st century not medieval Transilvania!
*cf. |